Skip to main content
Erschienen in: Quality of Life Research 9/2014

01.11.2014 | Brief Communication

Diminishing marginal disutility of hypoglycaemic events: results from a time trade-off survey in five countries

verfasst von: Jørgen T. Lauridsen, Jonas Lønborg, Jens Gundgaard, Henrik Holm Jensen

Erschienen in: Quality of Life Research | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The negative impact of hypoglycaemic events on health-related quality of life (HRQoL) may be evaluated by attaching published disutilities to these events. It is suggested that the marginal negative impact of individual hypoglycaemic events on HRQoL may decrease as the overall frequency increases.

Methods

Using disutility values from a large-scale (>8,000 respondents), time trade-off (TTO) study, nonlinear regression curves were fitted to the total disutility of different frequencies of non-severe daytime and nocturnal hypoglycaemic events. Nonparametric bootstrapping was applied to characterise the uncertainty of the marginal disutility.

Results

Power function regression curves were estimated at U d = 0.0141x 0.3393 and U d = 0.0221x 0.3277. An increase from 0 to 1 hypoglycaemic event per year produced a utility decrease of 0.0141 and 0.0221 for non-severe daytime and nocturnal events, respectively. An increase from 25 to 26 events per year produced a marginal impact of 0.0006 and 0.0008 for non-severe daytime and nocturnal events, respectively.

Discussion

These data concur with the noted phenomenon of “first being worst” as regards hypoglycaemic events. This finding may reflect a coping mechanism on the part of patients, a maximum limit for trading off remaining lifetime or the nature of the study.

Conclusion

Applying nonlinear functions to the TTO data might improve the precision of the measured impact of hypoglycaemic events.
Literatur
1.
Zurück zum Zitat UK Prospective Diabetes Study (UKPDS) Group. (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 352, 837–853.CrossRef UK Prospective Diabetes Study (UKPDS) Group. (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 352, 837–853.CrossRef
2.
Zurück zum Zitat Hepburn, D. A. (1993). Symptoms of hypoglycemia. In B. M. Frier (Ed.), Hypoglycemia and diabetes: Clinical and physiological aspects. London: Edward Arnold. Hepburn, D. A. (1993). Symptoms of hypoglycemia. In B. M. Frier (Ed.), Hypoglycemia and diabetes: Clinical and physiological aspects. London: Edward Arnold.
3.
Zurück zum Zitat American Diabetes Association Workgroup on Hypoglycaemia. (2005). Defining and reporting hypoglycemia in diabetes: A report from the American Diabetes Association workgroup on hypoglycemia. Diabetes Care, 28, 1245–1249.CrossRef American Diabetes Association Workgroup on Hypoglycaemia. (2005). Defining and reporting hypoglycemia in diabetes: A report from the American Diabetes Association workgroup on hypoglycemia. Diabetes Care, 28, 1245–1249.CrossRef
4.
Zurück zum Zitat Yale, J.-F., Begg, I., Gerstein, H., Houlden, R., Jones, H., Maheux, P., et al. (2002). 2001 Canadian Diabetes Association clinical practice guidelines for the prevention and management of hypoglycemia in diabetes. Canadian Journal of Diabetes, 26, 22–35. Yale, J.-F., Begg, I., Gerstein, H., Houlden, R., Jones, H., Maheux, P., et al. (2002). 2001 Canadian Diabetes Association clinical practice guidelines for the prevention and management of hypoglycemia in diabetes. Canadian Journal of Diabetes, 26, 22–35.
5.
Zurück zum Zitat Donnelly, L. A., Morris, A. D., Frier, B. M., Ellis, J. D., Donnan, P. T., Durrant, R., et al. (2009). Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: A population-based study. Diabetic Medicine, 22, 749–755.CrossRef Donnelly, L. A., Morris, A. D., Frier, B. M., Ellis, J. D., Donnan, P. T., Durrant, R., et al. (2009). Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: A population-based study. Diabetic Medicine, 22, 749–755.CrossRef
6.
Zurück zum Zitat Fidler, C., Elmelund Christensen, T., & Gillard, S. (2011). Hypoglycemia: An overview of fear of hypoglycemia, quality-of-life, and impact on costs. Journal of Medical Economics, 14, 646–655.PubMedCrossRef Fidler, C., Elmelund Christensen, T., & Gillard, S. (2011). Hypoglycemia: An overview of fear of hypoglycemia, quality-of-life, and impact on costs. Journal of Medical Economics, 14, 646–655.PubMedCrossRef
7.
Zurück zum Zitat Alvarez-Guisasola, F., Yin, D. D., Nocea, G., Qiu, Y., & Mavros, P. (2010). Association of hypoglycemic symptoms with patients’ rating of their health-related quality of life state: A cross sectional study. Health and Quality of Life Outcomes, 8, 86.PubMedCrossRefPubMedCentral Alvarez-Guisasola, F., Yin, D. D., Nocea, G., Qiu, Y., & Mavros, P. (2010). Association of hypoglycemic symptoms with patients’ rating of their health-related quality of life state: A cross sectional study. Health and Quality of Life Outcomes, 8, 86.PubMedCrossRefPubMedCentral
8.
Zurück zum Zitat Clarke, P., Gray, A., & Holman, R. (2002). Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Medical Decision Making, 22, 340–349.PubMedCrossRef Clarke, P., Gray, A., & Holman, R. (2002). Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Medical Decision Making, 22, 340–349.PubMedCrossRef
9.
Zurück zum Zitat Weinstein, M. C., Torrance, G., & McGuire, A. (2009). QALYs: The basics. Value in Health, 12(Suppl 1), S5–S9.PubMedCrossRef Weinstein, M. C., Torrance, G., & McGuire, A. (2009). QALYs: The basics. Value in Health, 12(Suppl 1), S5–S9.PubMedCrossRef
15.
Zurück zum Zitat Evans, M., Khunti, K., Mamdani, M., Galbo-Jørgensen, C., Gundgaard, J., Bøgelund, M., et al. (2013). Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: A time trade-off survey in five countries. Health and Quality of Life Outcomes, 11, 90. doi:10.1186/1477-7525-11-90.PubMedCrossRefPubMedCentral Evans, M., Khunti, K., Mamdani, M., Galbo-Jørgensen, C., Gundgaard, J., Bøgelund, M., et al. (2013). Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: A time trade-off survey in five countries. Health and Quality of Life Outcomes, 11, 90. doi:10.​1186/​1477-7525-11-90.PubMedCrossRefPubMedCentral
16.
Zurück zum Zitat Efron, B., & Tibshirani, R. (1993). An introduction to the bootstrap. Boca Raton, FL: Chapman and Hall/CRC.CrossRef Efron, B., & Tibshirani, R. (1993). An introduction to the bootstrap. Boca Raton, FL: Chapman and Hall/CRC.CrossRef
17.
Zurück zum Zitat Marrett, E., Radican, L., Davies, M. J., & Zhang, Q. (2011). Assessment of severity and frequency of self-reported hypoglycemia on quality of life in patients with type 2 diabetes treated with oral antihyperglycemic agents: A survey study. BMC Research Notes, 4, 251. doi:10.1186/1756-0500-4-251.PubMedCrossRefPubMedCentral Marrett, E., Radican, L., Davies, M. J., & Zhang, Q. (2011). Assessment of severity and frequency of self-reported hypoglycemia on quality of life in patients with type 2 diabetes treated with oral antihyperglycemic agents: A survey study. BMC Research Notes, 4, 251. doi:10.​1186/​1756-0500-4-251.PubMedCrossRefPubMedCentral
18.
Zurück zum Zitat Levy, A. R., Christensen, T. L., & Johnson, J. A. (2008). Utility values for symptomatic non-severe hypoglycaemia elicited from persons with and without diabetes in Canada and the United Kingdom. Health and Quality of Life Outcomes, 6, 73.PubMedCrossRefPubMedCentral Levy, A. R., Christensen, T. L., & Johnson, J. A. (2008). Utility values for symptomatic non-severe hypoglycaemia elicited from persons with and without diabetes in Canada and the United Kingdom. Health and Quality of Life Outcomes, 6, 73.PubMedCrossRefPubMedCentral
19.
Zurück zum Zitat Allen, K. V., & Frier, B. M. (2003). Nocturnal hypoglycemia: Clinical manifestations and therapeutic strategies toward prevention. Endocrine Practice, 9, 530–543.PubMedCrossRef Allen, K. V., & Frier, B. M. (2003). Nocturnal hypoglycemia: Clinical manifestations and therapeutic strategies toward prevention. Endocrine Practice, 9, 530–543.PubMedCrossRef
20.
Zurück zum Zitat Vexiau, P., Mavros, P., Krishnarajah, G., Lyu, R., & Yin, D. (2008). Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France. Diabetes, Obesity and Metabolism, 10(Suppl. 1), 16–24.PubMedCrossRef Vexiau, P., Mavros, P., Krishnarajah, G., Lyu, R., & Yin, D. (2008). Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France. Diabetes, Obesity and Metabolism, 10(Suppl. 1), 16–24.PubMedCrossRef
21.
Zurück zum Zitat Greene, W. H. (1999). Econometric analysis (4th ed.). Upper Saddle River, New Jersey: Prentice Hall. Greene, W. H. (1999). Econometric analysis (4th ed.). Upper Saddle River, New Jersey: Prentice Hall.
22.
Zurück zum Zitat Briggs, A., Claxton, K., & Sculpher, M. (2006). Decision modelling for health economic evaluation. UK: Oxford. Briggs, A., Claxton, K., & Sculpher, M. (2006). Decision modelling for health economic evaluation. UK: Oxford.
23.
Zurück zum Zitat Wooldridge, J. M. (2012). Introductory econometric analysis: A modern approach south-western/CENGAGE learning (4th ed.). UK: Hampshire. Wooldridge, J. M. (2012). Introductory econometric analysis: A modern approach south-western/CENGAGE learning (4th ed.). UK: Hampshire.
24.
Zurück zum Zitat Harris, S. B., Khunti, K., Landin-Olsson, M., Galbo-Jørgensen, C. B., Bøgelund, M., Chubb, M., et al. (2013). Descriptions of health states associated with increasing severity and frequency of hypoglycemia: A patient-level perspective. Patient Preference and Adherence, 16, 925–936.CrossRef Harris, S. B., Khunti, K., Landin-Olsson, M., Galbo-Jørgensen, C. B., Bøgelund, M., Chubb, M., et al. (2013). Descriptions of health states associated with increasing severity and frequency of hypoglycemia: A patient-level perspective. Patient Preference and Adherence, 16, 925–936.CrossRef
25.
Zurück zum Zitat Currie, C. J., Morgan, C. L., Poole, C. D., Sharplin, P., Lammert, M., & McEwan, P. (2006). Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes. Current Medical Research and Opinion, 22, 1523–1534.PubMedCrossRef Currie, C. J., Morgan, C. L., Poole, C. D., Sharplin, P., Lammert, M., & McEwan, P. (2006). Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes. Current Medical Research and Opinion, 22, 1523–1534.PubMedCrossRef
26.
Zurück zum Zitat Drummond, M. (2001). Introducing economic and quality of life measurements into clinical studies. Annals of Medicine, 33, 344–349.PubMedCrossRef Drummond, M. (2001). Introducing economic and quality of life measurements into clinical studies. Annals of Medicine, 33, 344–349.PubMedCrossRef
27.
Zurück zum Zitat Walters, S. J., & Brazier, J. E. (2005). Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Quality of Life Research, 14, 1523–1532.PubMedCrossRef Walters, S. J., & Brazier, J. E. (2005). Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Quality of Life Research, 14, 1523–1532.PubMedCrossRef
28.
Zurück zum Zitat Luo, N., Johnson, J. A., & Coons, S. J. (2010). Using instrument-defined health state transitions to estimate minimally important differences for four preference-based health-related quality of life instruments. Medical Care, 48, 365–371.PubMedCrossRef Luo, N., Johnson, J. A., & Coons, S. J. (2010). Using instrument-defined health state transitions to estimate minimally important differences for four preference-based health-related quality of life instruments. Medical Care, 48, 365–371.PubMedCrossRef
29.
Zurück zum Zitat Feeny, D. (2005). Preference-based measures: Utility and quality-adjusted life years, Chapter 6.2. In P. Fayers & R. Hays (Eds.), Assessing quality of life in clinical trials (2nd ed., pp. 405–429). Oxford: Oxford University Press. Feeny, D. (2005). Preference-based measures: Utility and quality-adjusted life years, Chapter 6.2. In P. Fayers & R. Hays (Eds.), Assessing quality of life in clinical trials (2nd ed., pp. 405–429). Oxford: Oxford University Press.
30.
Zurück zum Zitat Brod, M., Christensen, T., Thomsen, T. L., & Bushnell, D. M. (2011). The impact of non-severe hypoglycemic events on work productivity and diabetes management. Value in Health, 14, 665–671.PubMedCrossRef Brod, M., Christensen, T., Thomsen, T. L., & Bushnell, D. M. (2011). The impact of non-severe hypoglycemic events on work productivity and diabetes management. Value in Health, 14, 665–671.PubMedCrossRef
Metadaten
Titel
Diminishing marginal disutility of hypoglycaemic events: results from a time trade-off survey in five countries
verfasst von
Jørgen T. Lauridsen
Jonas Lønborg
Jens Gundgaard
Henrik Holm Jensen
Publikationsdatum
01.11.2014
Verlag
Springer International Publishing
Erschienen in
Quality of Life Research / Ausgabe 9/2014
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-014-0712-x

Weitere Artikel der Ausgabe 9/2014

Quality of Life Research 9/2014 Zur Ausgabe